{"entity":{"id":"hpv-programme-brazil","kind":"term","name":"HPV vaccination programme in Brazil","aka":["National HPV vaccination programme: Brazil"],"tldr":"Brazil offers girls and boys vaccination against human papillomavirus (HPV) in its national schedule, introduced in 2013; WHO's latest schedule lists one dose for those aged 9 to 14.","summary":"WHO's immunization data record HPV vaccine as introduced in Brazil in 2013 (a partial introduction that year). In the 2025 data the introduction is recorded as nationwide and the country reports a one-dose schedule. The routine schedule reported to WHO for 2025 gives one dose of quadrivalent vaccine to girls and boys aged 9 to 14. The country's note in the WHO schedule table reads: \"females 9-14 years; males 11-14 years; and men and women 9-26 years of special risk groups receive three doses (1st contact, +2 months, +6 months)\". WHO also lists additional doses for risk groups or catch-up cohorts in the same table. For hepatitis B vaccine, WHO records the birth dose as in the schedule in 2025.","asOf":"2026-11-04","links":[{"label":"WHO immunization data: introduction of HPV vaccine","url":"https://immunizationdata.who.int/global/wiise-detail-page/introduction-of-hpv-(human-papilloma-virus)-vaccine"},{"label":"WHO immunization data: HPV vaccination schedules","url":"https://immunizationdata.who.int/global/wiise-detail-page/vaccination-schedule-for-human-papilloma-virus"},{"label":"WHO xMart API rows for Brazil (HPV introduction)","url":"https://xmart-api-public.who.int/WIISE/MT_AD_INTRO_LONG?$filter=ANTIGEN%20eq%20'HPV'%20and%20ISO_3_CODE%20eq%20'BRA'"}],"tags":["vaccination-programme"],"related":["who-immunization-data"],"cancers":["cervical"],"sections":["prevention"],"technologies":["hpv-vaccine"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":["oncogenic-viruses"],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Epidemiology & prevention"},"route":"/terms/hpv-programme-brazil/","neighbours":{"collection":[{"id":"who-immunization-data","kind":"collection","name":"WHO immunization data portal (WIISE)","route":"/collections/who-immunization-data/"}],"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"section":[{"id":"prevention","kind":"section","name":"Prevention & Risk","route":"/fronts/prevention/"}],"technology":[{"id":"hpv-vaccine","kind":"technology","name":"HPV & HBV vaccination","route":"/technologies/hpv-vaccine/"}],"pathway":[{"id":"oncogenic-viruses","kind":"pathway","name":"Oncogenic viruses","route":"/pathways/oncogenic-viruses/"}],"term":[{"id":"hpv-gender-neutral-programmes","kind":"term","name":"HPV vaccination of boys as well as girls, by country","route":"/terms/hpv-gender-neutral-programmes/"},{"id":"hpv-single-dose-adoption","kind":"term","name":"Single-dose HPV vaccination schedules by country","route":"/terms/hpv-single-dose-adoption/"}]}}